Skip to main content
. Author manuscript; available in PMC: 2019 Jun 14.
Published in final edited form as: Nanomedicine (Lond). 2009 Apr;4(3):331–339. doi: 10.2217/nnm.09.8

Figure 1. Targeting of nanoparticles to tumor EGF receptor.

Figure 1.

(A) Hematoxylin and eosin staining shows a small nodule; (B) fluorescence staining of dye-conjugated nanoparticles (green) confirms localization to the nodule; (C) staining with anti-EGF receptor (EGFR; brown) demonstrates overexpression of EGFR in the same region.

Reproduced from [12] with permission from Elsevier © (2008).